Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in Rhabdomyosarcoma

1 Apr 1997

Abstract excerpt

A subtractive cloning procedure was used to characterize the molecular changes involved in transformation of normal myoblasts to rhabdomyosarcoma (RMS) cells. Here we describe the cloning of DRAL, a novel LIM-domain protein expressed in primary myoblasts but down-regulated in the RMS cell line RD. DRAL is a LIM-only protein with five LIM domains whereby one LIM domain consists only of the second half of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Galectins and Cancer Biology
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9150430
DOI: 10.1089/dna.1997.16.433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Subtractive Cloning and Characterization of DRAL, a Novel LIM-Domain Protein Down-Regulated in RhabdomyosarcomaPMID 9150430Read ↗

Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces ApoptosisSemantic proximity Read ↗

Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcomaSemantic proximity Read ↗

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cellsSemantic proximity Read ↗

Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family membersSemantic proximity Read ↗

MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesisSemantic proximity Read ↗

Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways.Semantic proximity Read ↗

CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.Semantic proximity Read ↗

Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription FactorsSemantic proximity Read ↗

TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cellsSemantic proximity Read ↗

MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRASemantic proximity Read ↗

RCOR1 promotes myoblast differentiation and muscle regenerationSemantic proximity Read ↗

SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.